Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | |
|---|---|---|---|---|---|---|
| Total revenue | 2.00%65.48M | 12.24%64.2M | 6.14%57.19M | 75.53%53.88M | 4.16%30.7M | 29.47M |
| Net interest income | 2.02%959K | 46.19%940K | 26.33%643K | 12.11%509K | -11.67%454K | --514K |
| -Net interest income | 2.02%959K | 46.19%940K | 26.33%643K | 12.11%509K | -11.67%454K | --514K |
| Non interest income | 2.00%64.52M | 11.86%63.26M | 5.95%56.55M | 76.48%53.37M | 4.44%30.24M | --28.96M |
| -Fees and commissions | --2.5M | ---- | 92.41%-190K | ---2.5M | ---- | ---- |
| -Other non interest income | -69.84%893K | -35.21%2.96M | -77.24%4.57M | 471.99%20.08M | 271.82%3.51M | --944K |
| -Dividend income | 1.38%61.12M | 15.57%60.29M | 45.72%52.17M | 33.92%35.8M | -4.57%26.73M | --28.01M |
| Credit losses provision | ||||||
| Non interest expense | 19.42%9.85M | 6.12%8.25M | 21.56%7.78M | 29.06%6.4M | 3.42%4.96M | 4.79M |
| Professional expense and contract services expense | 19.65%7.48M | 5.38%6.25M | 21.57%5.93M | 30.23%4.88M | 6.60%3.75M | --3.52M |
| Selling and administrative expenses | 15.07%542K | 19.85%471K | 18.73%393K | 7.82%331K | -26.73%307K | --419K |
| -General and administrative expense | 15.07%542K | 19.85%471K | 18.73%393K | 7.82%331K | -26.73%307K | --419K |
| Other non-interest expense | 19.78%1.83M | 5.46%1.53M | 22.30%1.45M | 31.41%1.18M | 5.13%901K | --857K |
| Income from associates and other participating interests | ||||||
| Special income (charges) | ||||||
| Other non-operating income (expenses) | 743.22%4.6M | 546K | ||||
| Income before tax | 6.62%60.23M | 14.31%56.49M | 4.06%49.42M | 84.48%47.49M | 4.31%25.74M | 24.68M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||
| Net income | 6.62%60.23M | 14.31%56.49M | 4.06%49.42M | 84.48%47.49M | 4.31%25.74M | 24.68M |
| Net Income continuous operations | 6.62%60.23M | 14.31%56.49M | 4.06%49.42M | 84.48%47.49M | 4.31%25.74M | --24.68M |
| Noncontrolling interests | ||||||
| Net income attributable to the company | 6.62%60.23M | 14.31%56.49M | 4.06%49.42M | 84.48%47.49M | 4.31%25.74M | 24.68M |
| Preferred stock dividends | ||||||
| Other under preferred stock dividend | ||||||
| Net income attributable to common stockholders | 6.62%60.23M | 14.31%56.49M | 4.06%49.42M | 84.48%47.49M | 4.31%25.74M | 24.68M |
| Diluted earnings per share | -10.77%0.1814 | 9.18%0.2033 | -13.48%0.1862 | 45.92%0.2152 | -0.60%0.1475 | 0.1484 |
| Basic earnings per share | -10.77%0.1814 | 9.18%0.2033 | -13.48%0.1862 | 45.92%0.2152 | -0.60%0.1475 | 0.1484 |
| Dividend per share | -7.80%0.1786 | 14.68%0.1937 | 25.88%0.1689 | 0.30%0.1342 | -9.23%0.1338 | 0.1474 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |